Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration

Wei Zhao(Xi'an Jiaotong University), Jingwen Liu(Hefei University of Technology), Yinwei Wu(Nanjing Second Hospital), Lan Wang(Nanjing Second Hospital), Haiyan Liu(John Cochran VA Medical Center), Chan Luo(Nanjing Second Hospital), Wei Chen(Jinshan Hospital of Fudan University), Yue Zhou(University of Toyama), Bin Jiang, Rong Xue(Nanjing Second Hospital), Wei Liu(Second Affiliated Hospital of Nanjing Medical University), Jian‐Dong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
International Journal of Oncology
May 1, 2006
10.3892/ijo.28.5.1081
Cited by 51

Related Papers

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
|Molecular Cancer|2019|637
Tumor biomarkers for diagnosis, prognosis and targeted therapy
|Signal Transduction and Targeted Therapy|2024|600
Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes
|Journal of Neurotrauma|2018|368
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus
|Nature Genetics|2008|317